跳至主要内容
临床试验/CTRI/2025/04/085799
CTRI/2025/04/085799尚未招募不适用

An observational study to estimate the prevalence of mLOX in women with hematological and solid malignancies

Armed Forces Medical College1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年10月5日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
To estimate mosaic loss of X chromosome in women with hematological and solid malignancies

研究概览

简要总结

Mosaic loss of x chromosome of mLOX is the phenomenon that may predict the loss of one copy of a woman’s two x chromosomes with age . The x chromosome inactivation has evolved as a mechanism to compensate for gene dosage imbalances between XX female and XY males , although some genes are only partially inactivated including the tumor suppressor genes(ATRX, KDM5C) . mLOX along with age related types of CH are important pre clinical indicators of hematological cancer risk and identify mitotic mis segregation , autoimmunity , blood cell trait and cancer pre disposition genes as core etiological components for mLOX susceptibility and selection. This study aims to estimate the mosaic loss of x chromosome in women with hematological and solid malignancies , to explore the association between mLOX and age of onset of malignancies and to explore association between mLOX , age of menarche/menopause in different malignancies

研究设计

研究类型
Observational

入排标准

年龄范围
40.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • All diagnosed patients with multiple myeloma as per IMWG criteria are eligible for inclusion.

排除标准

  • premature ovarian failure turner females known sex chromosome disorders hormone replacement therapy history.

结局指标

主要结局

To estimate mosaic loss of X chromosome in women with hematological and solid malignancies

时间窗: Cross sectional study | Single time point evaluation

次要结局

  • to explore association between mLOX & age at onset of malignancies(To explore the association between mLOX age of menarche menopause in different malignancies)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验